| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 2 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Greece | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | United States | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | Australia | 1 | |
| #8 | Brazil | 1 | |
| #9 | Morocco | 1 | |
| #10 | Mexico | 1 | |
| #11 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Boulikas Parthenios | 15 |
| #2 | Roberts Michael | 5 |
| #3 | Pages Jean Christophe | 1 |
| Publication | Filing date | Title |
|---|---|---|
| GR20060100496A | LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAi CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES. | |
| GR20060100144A | Cancer treatment using oxaliplatin encapsulated into liposomes and co-encapsulation into the liposome particle of more than one pharmaceutical preparations, or genes |